Precision BioSciences stockholders approve 3.8M share increase for incentive plan
Precision BioSciences, Inc. stockholders approved an amendment to the 2019 Incentive Award Plan, increasing the number of shares available for issuance by an additional 3,800,000. This approval occurred at the annual meeting on May 21, 2026. Stockholders also approved an amendment to the Certificate of Incorporation to exculpate certain officers as permitted by Delaware law, which became effective on May 22, 2026. Additionally, two Class I directors were elected, the appointment of Deloitte & Touche LLP as auditor was ratified, and executive compensation was approved on an advisory basis.
Key Highlights
- Stockholders approved an increase of 3,800,000 shares for the 2019 Incentive Award Plan.
- The 2019 Incentive Award Plan amendment passed with 11,170,635 votes FOR.
- Amendment for officer exculpation approved with 17,909,703 votes FOR.
- Melinda Brown and Geno Germano were elected as Class I directors.
- Deloitte & Touche LLP was ratified as the independent auditor with 22,198,597 votes FOR.
- Advisory approval of executive compensation passed with 18,696,193 votes FOR.
- Approximately 86% of common stock outstanding was represented at the annual meeting.
Price Impact
More from DTIL
Precision BioSciences Q2: HBV cccDNA Eliminated, Cash to 2028
Precision BioSciences Q2 Net Loss $(32.65)M; Extends Loan Maturity to 2029
Precision BioSciences promotes Alex Kelly to COO, appoints Naresh Tanna CFO